Posted by Michael Wonder on 24 Jul 2017
Nicotine replacement therapy
21 July 2017 - PHARMAC proposes to continue to fund the Habitrol brand of nicotine gum, lozenges and patches supplied by GSK Consumer Healthcare.
From 1 January 2018, the price and subsidy of Habitrol brand NRT would increase. From 1 April 2018, a new 1-week pack size would be available to Authorised Providers and Sole Supply Status and Hospital Supply Status, with a 1% DV Limit for hospitals, for nicotine gum, lozenges and patches would be applied to GSK’s Habitrol brand until 30 June 2020.
There would be an option of PHARMAC extending the sole supply period for a further two years.
